22:41 , Jun 10, 2019 |  BC Innovations  |  Distillery Therapeutics

Recombinant DAG1 for influenza

DISEASE CATEGORY: Infectious disease INDICATION: Influenza virus Mouse studies suggest the N-terminal domain of the lung extracellular matrix receptor DAG1 could help treat influenza A virus infection. In a mouse model of influenza A virus...
07:00 , Sep 13, 2012 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Conditional fukutin (Fktn) knockout mice as a model for secondary dystroglycanopathies Conditional Fktn knockout mice could be useful models for secondary dystroglycanopathies, a family of...
07:00 , Jul 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1; β3GNT1); dystroglycan 1 (DAG1) Studies in mice and cell culture suggest that activating the β3GNT1 and DAG1 signaling pathways could help...